Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dupont Merck
Patients will be given combination treatment with efavirenz, stavudine, and didanosine.
Age
13–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have:
Documented HIV infection with plasma HIV-RNA greater than or equal to 10,000 copies/ml.
A life expectancy of at least 12 months.
You may not be if
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Current bilateral peripheral neuropathy greater than or equal to Grade 2.
Any clinically significant laboratory findings obtained during the screening evaluation (see laboratory values).
Any clinically significant disease (other than HIV infection) or clinically significant findings during screening of medical history or physical examination.
Any malignancy that requires systemic therapy.
Proven or suspected acute hepatitis due to any cause.
Recurrent episodes of moderate to severe diarrhea, or vomiting lasting more than 4 days within 3 months prior to dosing.
Active AIDS-defining opportunistic infection or disease.
